UNSPSC 51342401: Nelfinavir

This classification denotes a protease inhibitor with the molecular formula C32H45N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HO3OGH5D7I, chemically known as 3-isoquinolinecarboxamide, n-(1,1-dimethylethyl)decahydro-2-((2r,3r)-2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3s,4as,8as)- but generally known as nelfinavir, which bears US NIH Compound Identifier 64143.

UNSPSC 51342401 Nelfinavir is a Commodity code that nominally covers a specific antiretroviral pharmaceutical product, but recent state and local opportunities show this code being used to tag procurement for a broader range of pharmaceutical products, medical supplies, and pharmacy benefit programs rather than nelfinavir specifically. The issuing bodies span county health departments, state health and human services commissions, municipal fire departments, and multistate cooperative purchasing alliances procuring generic pharmaceuticals, over-the-counter products, naloxone, and medical-surgical supplies for emergency response and public health programs. The work reflects a shift toward direct-to-manufacturer contracting models, competitive bidding for bulk pharmaceutical and medical supply fulfillment, and cooperative purchasing arrangements that consolidate demand across multiple jurisdictions to achieve volume pricing and supply chain efficiency.

Recent activity concentrates in Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS (posted June 30, 2026, due July 26, 2026) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The Texas Health and Human Services Commission posted RFI HHS0017013 (April 3, 2026) soliciting vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program to establish direct relationships between the state's pharmacy benefit program and pharmaceutical manufacturers outside traditional pharmacy benefit manager and group purchasing organization channels. The City of Tampa Purchasing Department issued IFB 26P00145 (due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount, estimated at $700,000. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities, including Oregon, with awards effective July 1, 2026.